CD64: An Attractive Immunotherapeutic Target for M1-type Macrophage Mediated Chronic Inflammatory Diseases.

MLA

Akinrinmade, Olusiji A., et al. “CD64: An Attractive Immunotherapeutic Target for M1-Type Macrophage Mediated Chronic Inflammatory Diseases.” Biomedicines, vol. 5, no. 3, Sept. 2017. EBSCOhost, https://doi.org/10.3390/biomedicines5030056.

APA

Akinrinmade, O. A., Chetty, S., Daramola, A. K., Islam, M.-U., Thepen, T., & Barth, S. (2017). CD64: An Attractive Immunotherapeutic Target for M1-type Macrophage Mediated Chronic Inflammatory Diseases. Biomedicines, 5(3). https://doi.org/10.3390/biomedicines5030056

Chicago

Akinrinmade, Olusiji A, Shivan Chetty, Adebukola K Daramola, Mukit-Ul Islam, Theo Thepen, and Stefan Barth. 2017. “CD64: An Attractive Immunotherapeutic Target for M1-Type Macrophage Mediated Chronic Inflammatory Diseases.” Biomedicines 5 (3). doi:10.3390/biomedicines5030056.